Sangeeta Bhatia

Sangeeta Bhatia

Directeur/Membre du Conseil chez VERTEX PHARMACEUTICALS INCORPORATED

Fortune : 3 M $ au 31/08/2026

57 ans
Health Technology
Commercial Services
Consumer Services

Profil

Sangeeta N.
Bhatia
is the founder of Hepregen Corp.
founded in 2007, Matrisome Bio, Inc. founded in 2023, Glympse Bio, Inc. founded in 2015, and Satellite Biosciences, Inc. founded in 2020 where Dr. Bhatia holds the title of Director.
Dr. Bhatia is also the founder of Port Therapeutics, Inc.,Impilo Therapeutics, Inc...
Dr. Bhatia currently serves as an Independent Director at Vertex Pharmaceuticals, Inc. since 2015, a Professor at Massachusetts Institute of Technology since 2005, a member of the Scientific Advisory Board at Cristal Delivery BV, a member of the Scientific Advisory Board at Maverick Therapeutics, Inc., and a Venture Partner at Catalio Capital Management LP.
Former positions include Member-Medicine Department at The Brigham & Women's Hospital, Inc., Professor at the University of California San Diego from 1998 to 2005, Member of the National Academy of Sciences, Member of the National Academy of Engineering, Member of the National Academy of Medicine (United States), Member of The Broad Institute, Inc., member of the Scientific Advisory Board at Lumicell, Inc., and Member of the David H.
Koch Institute for Integrative Cancer Research.
Education includes undergraduate studies at Brown University, a doctorate from Harvard Medical School, and a doctorate from Massachusetts Institute of Technology conferred in 1997.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
04/05/2026 4 924 ( 0% ) 3 M $ 31/08/2026

Postes actifs de Sangeeta Bhatia

SociétésPosteDébut
VERTEX PHARMACEUTICALS INCORPORATED Directeur/Membre du Conseil 18/06/2015
Fondateur -
Consultant / Advisor -
Consultant / Advisor -
Private Equity Investor -
Fondateur 01/01/2020
Corporate Officer/Principal 01/03/2005
Fondateur -

Anciens postes connus de Sangeeta Bhatia

SociétésPosteFin
Corporate Officer/Principal 01/01/2005
░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░ ░░ ░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░ ░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de Sangeeta Bhatia

Formation de Sangeeta Bhatia

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

91

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées21

Health Technology

Health Technology

Consumer Services

Health Services

Finance

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

Consumer Services

Electronic Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Technology Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Sangeeta Bhatia
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT